Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 3642832, 14 pages
https://doi.org/10.1155/2017/3642832
Research Article

Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis

1Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2363, USA
2Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232-2363, USA
3Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT 06520, USA
4Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2363, USA

Correspondence should be addressed to Wonder P. Drake; ude.tlibrednav@ekard.rednow

Received 13 June 2017; Accepted 26 September 2017; Published 6 November 2017

Academic Editor: Stuart Berzins

Copyright © 2017 Charlene Hawkins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Judson, “The clinical features of sarcoidosis: a comprehensive review,” Clinical Reviews in Allergy & Immunology, vol. 49, no. 1, pp. 63–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Prasse, C. G. Georges, H. Biller et al., “Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells,” Clinical and Experimental Immunology, vol. 122, no. 2, pp. 241–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. B. W. Robinson, T. L. McLemore, and R. G. Crystal, “Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis,” Journal of Clinical Investigation, vol. 75, no. 5, pp. 1488–1495, 1985. View at Publisher · View at Google Scholar
  4. I. Tsiligianni, K. M. Antoniou, D. Kyriakou et al., “Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis,” BMC Pulmonary Medicine, vol. 5, p. 8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. N. A. Braun, L. J. Celada, J. D. Herazo-Maya et al., “Blockade of the programmed death-1 pathway restores sarcoidosis CD4+ T-cell proliferative capacity,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 5, pp. 560–571, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. N. S. Lee, L. Barber, A. Kanchwala et al., “Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis,” Clinical and Vaccine Immunology, vol. 18, no. 2, pp. 223–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. S. Lee, L. Barber, S. M. Akula, G. Sigounas, Y. P. Kataria, and S. Arce, “Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis,” Clinical and Vaccine Immunology, vol. 18, no. 8, pp. 1306–1316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. Oswald-Richter, B. W. Richmond, N. A. Braun et al., “Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis,” The Journal of Immunology, vol. 190, no. 11, pp. 5446–5453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. B. W. Richmond, K. Ploetze, J. Isom et al., “Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression,” Journal of Clinical Immunology, vol. 33, no. 2, pp. 446–455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. E. J. Wherry, “T cell exhaustion,” Nature Immunology, vol. 12, no. 6, pp. 492–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. J. Wherry and M. Kurachi, “Molecular and cellular insights into T cell exhaustion,” Nature Reviews Immunology, vol. 15, no. 8, pp. 486–499, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Araki, B. Youngblood, and R. Ahmed, “Programmed cell death 1-directed immunotherapy for enhancing T-cell function,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Duraiswamy, C. C. Ibegbu, D. Masopust et al., “Phenotype, function, and gene expression profiles of programmed death-1hi CD8 T cells in healthy human adults,” The Journal of Immunology, vol. 186, no. 7, pp. 4200–4212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Jiang, Y. Li, and B. Zhu, “T-cell exhaustion in the tumor microenvironment,” Cell Death and Disease, vol. 6, no. 6, article e1792, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. G. W. Hunninghake, U. Costabel, M. Ando et al., “ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of sarcoidosis and other granulomatous disorders,” Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, vol. 16, no. 2, pp. 149–173, 1999. View at Google Scholar
  16. K. A. Oswald-Richter, D. A. Culver, C. Hawkins et al., “Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis,” Infection and Immunity, vol. 77, no. 9, pp. 3740–3748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. Oswald-Richter, D. C. Beachboard, X. Zhan et al., “Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis,” Respiratory Research, vol. 11, p. 161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Pinkston, P. B. Bitterman, and R. G. Crystal, “Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis,” New England Journal of Medicine, vol. 308, no. 14, pp. 793–800, 1983. View at Publisher · View at Google Scholar
  19. H. Gudmundsdottir and L. A. Turka, “A closer look at homeostatic proliferation of CD4+ T cells: costimulatory requirements and role in memory formation,” The Journal of Immunology, vol. 167, no. 7, pp. 3699–3707, 2001. View at Publisher · View at Google Scholar
  20. E. J. Wherry, J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed, “Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment,” Journal of Virology, vol. 77, no. 8, pp. 4911–4927, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. E. J. Wherry and R. Ahmed, “Memory CD8 T-cell differentiation during viral infection,” Journal of Virology, vol. 78, no. 11, pp. 5535–5545, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Moskophidis, F. Lechner, H. Pircher, and R. M. Zinkernagel, “Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells,” Nature, vol. 362, no. 6422, pp. 758–761, 1993. View at Publisher · View at Google Scholar
  23. A. J. Zajac, J. N. Blattman, K. Murali-Krishna et al., “Viral immune evasion due to persistence of activated T cells without effector function,” The Journal of Experimental Medicine, vol. 188, no. 12, pp. 2205–2213, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. S. D. Blackburn, H. Shin, W. N. Haining et al., “Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection,” Nature Immunology, vol. 10, no. 1, pp. 29–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Crawford and E. J. Wherry, “Inhibitory receptors: whose side are they on?” Nature Immunology, vol. 8, no. 11, pp. 1201–1203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Yi, M. A. Cox, and A. J. Zajac, “T-cell exhaustion: characteristics, causes and conversion,” Immunology, vol. 129, no. 4, pp. 474–481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. E. J. Wherry, S. J. Ha, S. M. Kaech et al., “Molecular signature of CD8+ T cell exhaustion during chronic viral infection,” Immunity, vol. 27, no. 4, pp. 670–684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Quigley, F. Pereyra, B. Nilsson et al., “Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF,” Nature Medicine, vol. 16, no. 10, pp. 1147–1151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. E. A. Said, F. P. Dupuy, L. Trautmann et al., “Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection,” Nature Medicine, vol. 16, no. 4, pp. 452–459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Shin, S. D. Blackburn, A. M. Intlekofer et al., “A role for the transcriptional repressor Blimp-1 in CD8+ T cell exhaustion during chronic viral infection,” Immunity, vol. 31, no. 2, pp. 309–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. R. P. Baughman, A. S. Teirstein, M. A. Judson et al., “Clinical characteristics of patients in a case control study of sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, Part 1, pp. 1885–1889, 2001. View at Publisher · View at Google Scholar
  32. M. A. Judson, A. D. Boan, and D. T. Lackland, “The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States,” Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, vol. 29, no. 2, pp. 119–127, 2012. View at Google Scholar
  33. J. E. Snyder-Cappione, D. F. Nixon, J. C. Chi et al., “Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis,” European Journal of Immunology, vol. 43, no. 8, pp. 2194–2205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. T. L. Murphy, R. Tussiwand, and K. M. Murphy, “Specificity through cooperation: BATF–IRF interactions control immune-regulatory networks,” Nature Reviews Immunology, vol. 13, no. 7, pp. 499–509, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Dirks, A. Egli, U. Sester, M. Sester, and H. H. Hirsch, “Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells,” Transplant Infectious Disease, vol. 15, no. 1, pp. 79–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. K. E. Pauken and E. J. Wherry, “Overcoming T cell exhaustion in infection and cancer,” Trends in Immunology, vol. 36, no. 4, pp. 265–276, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Raghuraman, H. Park, W. O. Osburn, E. Winkelstein, B. R. Edlin, and B. Rehermann, “Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion,” The Journal of Infectious Diseases, vol. 205, no. 5, pp. 763–771, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R. N. Mahon, R. E. Rojas, S. A. Fulton, J. L. Franko, C. V. Harding, and W. H. Boom, “Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell-receptor signaling,” Infection and Immunity, vol. 77, no. 10, pp. 4574–4583, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. N. Mahon, O. J. Sande, R. E. Rojas, A. D. Levine, C. V. Harding, and W. H. Boom, “Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation,” Cellular Immunology, vol. 275, no. 1-2, pp. 98–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. O. J. Sande, A. F. Karim, Q. Li et al., “Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis induces CD4+ T cell anergy via GRAIL,” The Journal of Immunology, vol. 196, no. 2, pp. 691–702, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. W. P. Drake and L. S. Newman, “Mycobacterial antigens may be important in sarcoidosis pathogenesis,” Current Opinion in Pulmonary Medicine, vol. 12, no. 5, pp. 359–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Oswald-Richter, H. Sato, R. Hajizadeh et al., “Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101,” Journal of Clinical Immunology, vol. 30, no. 1, pp. 157–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. L. S. Newman, “Aetiologies of sarcoidosis,” in European Respiratory Monograph: Sarcoidosis, M. Drent and U. Costabel, Eds., pp. 23–48, European Respiratory Society Journals Ltd., Sheffield, UK, 32 edition, 2005. View at Publisher · View at Google Scholar
  44. M. Rossman, B. Thompson, M. Frederick, B. Cizman, E. Magira, and D. Monos, “Sarcoidosis: association with human leukocyte antigen class II amino acid epitopes and interaction with environmental exposures,” Chest, vol. 121, Supplement 3, p. 14S, 2002. View at Publisher · View at Google Scholar
  45. M. D. Rossman, B. Thompson, M. Frederick et al., “HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites,” The American Journal of Human Genetics, vol. 73, no. 4, pp. 720–735, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Sato, F. A. Woodhead, T. Ahmad et al., “Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups,” Human Molecular Genetics, vol. 19, no. 20, pp. 4100–4111, 2010. View at Publisher · View at Google Scholar · View at Scopus